Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 10.20
-0.40 (-3.92%)
Apr 20, 2026, 1:12 PM CST
Pharmigene Market Cap
Pharmigene has a market cap or net worth of 514.74 million as of April 20, 2026. Its market cap has decreased by -29.66% in one year.
Market Cap
514.74M
Enterprise Value
1.06B
Revenue
149.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.20
Market Cap Chart
Since December 22, 2020, Pharmigene's market cap has decreased from 1.08B to 514.74M, a decrease of -52.44%. That is a compound annual growth rate of -13.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 514.74M | 3.03% |
| Dec 31, 2025 | 499.60M | -30.53% |
| Dec 31, 2024 | 719.13M | -31.16% |
| Dec 29, 2023 | 1.04B | 21.08% |
| Dec 30, 2022 | 862.78M | -8.53% |
| Dec 30, 2021 | 943.19M | -13.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 242.37B |
| Caliway Biopharmaceuticals | 168.09B |
| Lotus Pharmaceutical | 61.63B |
| Heron Neutron Medical | 61.19B |
| Vectorite Biomedical | 643.44M |
| Golden Biotechnology | 562.93M |
| Health & Life | 545.19M |
| Taiwan Advanced Nanotech | 470.20M |